Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial-Reference-Cited by-同舟云学术

Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial

Published:2016-03 Issue:10 Volume:67 Page:1145-1154
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Storey Robert F.,Angiolillo Dominick J.,Bonaca Marc P.,Thomas Mark R.,Judge Heather M.,Rollini Fabiana,Franchi Francesco,Ahsan Arif J.,Bhatt Deepak L.,Kuder Julia F.,Steg Philippe Gabriel,Cohen Marc,Muthusamy Rangasamy,Braunwald Eugene,Sabatine Marc S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Novel antiplatelet agents in acute coronary syndrome;Franchi;Nat Rev Cardiol,2015

2. Randomized double-blind assessment of the ONSET and OFFSet of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study;Gurbel;Circulation,2009

3. Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes;Storey;J Am Coll Cardiol,2007

4. Inhibitory effects of ticagrelor compared to clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET Substudy;Storey;J Am Coll Cardiol,2010

5. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N Engl J Med,2009

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic coronary syndromes: diagnosis, management and gaps in evidence;Heart, Vessels and Transplantation;2024-08-28

2. Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial;European Heart Journal - Cardiovascular Pharmacotherapy;2024-07-18

3. P2Y12 Inhibition in Patients Requiring Oral Anticoagulation after Percutaneous Coronary Intervention: The SWAP-AC–2 Study;JACC: Cardiovascular Interventions;2024-04

4. Antiplatelet Therapy After PCI: The Art and Science of De-Escalation;Circulation;2024-02-20

5. Population Pharmacokinetic/Pharmacodynamic Models for P2Y12 Inhibitors: A Systematic Review and Clinical Appraisal Using Exposure Simulation;Clinical Pharmacokinetics;2024-01-20